Previous Article | Next Article 
Journal of Clinical Microbiology, October 2008, p. 3498-3500, Vol. 46, No. 10
0095-1137/08/$08.00+0 doi:10.1128/JCM.00982-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Production of White Colonies on CHROMagar Candida Medium by Members of the Candida glabrata Clade and Other Species with Overlapping Phenotypic Traits
Justin A. Bishop,1
Nancy Chase,1,
Richard Lee,1
Cletus P. Kurtzman,2 and
William G. Merz1*
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland,1
Microbial Genomics and Bioprocessing Research Unit, National Center for Agricultural Utilization Research, Agricultural Research Service, U.S. Department of Agriculture, Peoria, Illinois2
Received 21 May 2008/
Returned for modification 7 July 2008/
Accepted 25 July 2008

ABSTRACT
We hypothesized that species of the
Candida glabrata clade and
species with phenotypic traits that overlap those of
C. glabrata would produce white colonies on CHROMagar
Candida medium. Of
154 isolates (seven species) tested,
C. bracarensis, C. nivariensis, C. norvegensis, C. glabrata, and
C. inconspicua produced white
colonies; the
Pichia fermentans group and
C. krusei did not.
Many of these species are difficult to identify phenotypically;
white colonies may signal the need for the use of molecular
approaches.

TEXT
Chromogenic media have been formulated to discern common
Candida species on the basis of the color of the colonies (
7). Beginning
in Europe in the 1990s, investigators published reports of the
development of several chromogenic media; many of the media
are now commercially available products in the United States.
These publications include several on the performance of CHROMagar
Candida medium (CAC; Becton Dickinson, Sparks, MD, and Hardy
Diagnostics, Santa Maria, CA). These data support the conclusions
that there are relatively specific colony colors for
Candida albicans, Candida tropicalis, and
Candida krusei (
2,
8,
11,
12). In addition,
Candida glabrata and
Candida dubliniensis can often be distinguished by their specific colony colors (
5,
9). A major advantage of these media is that they provide identifications
(presumptive or definitive) in times shorter than those required
for identification by many standard mycologic phenotypic assays
(
11). In addition, these media permit the detection of the growth
of multiple yeast species from a single clinical specimen due
to the colony color differences (
8,
11). However, the lack of
a wide range of colors limits the expansion to more yeast genera
or species, and the increased cost (higher than that for standard
mycologic media) has prevented some laboratories from implementing
these media.
Since its original descriptions, there have been reports of yeast species that produce white colonies on CAC (8). However, white colony-producing yeasts are not frequently encountered among yeasts recovered from clinical specimens (7, 8, 12). We recently observed white colonies while investigating Candida bracarensis and Candida nivariensis (3), two species within the C. glabrata clade recently defined molecularly (1, 4). These species are difficult to separate by the use of phenotyping due to their significantly overlapping traits and also due to the relatively few positive reactions for these species (e.g., by a carbohydrate assimilation assay). From these observations, we hypothesized that white colonies would be produced on CAC by other strains or members of the C. glabrata clade and also by Candida spp. that are not in the clade but that have few positive reactions and that share many phenotypic traits.
A total of 154 isolates was tested in this study, including 13 C. krusei and 127 C. glabrata recent clinical isolates identified by phenotypic characteristics at the Clinical Mycology Laboratory of The Johns Hopkins Hospital. Phenotypic identification of C. glabrata and C. krusei was made by the germ tube assay; the urease test; determination of microscopic morphology on cornmeal agar with Tween 80; the phenoloxidase enzyme assay; and fermentation patterns on glucose, maltose, sucrose, lactose, galactose, trehalose, and cellobiose. Fourteen reference type strains and clinical laboratory reference strains of seven other Candida species were also tested (Table 1). Each isolate was coded to blind the reader and streaked onto the surfaces of three CAC plates; one set of plates was incubated at 25°C, one at 30°C, and one at 37°C. The plates were read independently by at least two readers after 24 and 48 h of incubation. An isolate was designated positive if it produced white colonies on CAC at two or three of the temperatures. All isolates that produced white colonies were reidentified by molecular assays, D1 and D2 sequencing (6), or peptide nucleic acid fluorescence in situ hybridization (3) and phenotypically by using the carbohydrate patterns obtained with the API 20C system (BioMerieux, Hazelwood, MO).
Numerous white colonies were noted after 24 h of incubation,
but many of these colonies developed into shades of pink and
occasionally purple after an additional 24 h of incubation.
Therefore, all subsequent results are from data collected after
48 h of incubation. The color distinction was the most pronounced
at 37°C and was the least pronounced at 25°C. Similarly,
although white colonies were noted at all three temperatures,
more white colonies were observed at 37°C than at 25°C
and 30°C. In addition, all "positives" (i.e., isolates that
grew as white colonies at two of the three temperatures) were
white at both 30°C and 37°C.
White colonies were produced by a total of 18 isolates representing five of the seven species tested (Table 2). The five species were C. glabrata, C. bracarensis, C. nivariensis, Candida norvegensis, and Candida inconspicua. The first three species are members of the C. glabrata clade, whereas C. inconspicua and C. norvegensis share phenotypic traits with C. glabrata but, along with C. krusei and C. inconspicua, are members of the Pichia membranifaciens/P. fermentans clade (6). The two species studied that did not produce any white colonies were C. krusei and the P. fermentans group, two species that also share phenotypic traits with members of the C. glabrata clade. These data support our hypothesis that members of the C. glabrata clade as well as distantly related species with overlapping phenotypic traits would produce white colonies on CAC.
Confirmations of the identifications of the 18 isolates by an
additional phenotypic assay (carbohydrate assimilation patterns
with the API 20C system) and by sequencing of the large subunits
D1 and D2 yielded interesting results (Table
2). The sequencing
data identified all 18 isolates to the species level, and the
identifications of 13 isolates were reconfirmed. Five isolates
whose identifications were not confirmed by sequencing were
among the eight recent clinical isolates of
C. glabrata. Molecularly,
four were
C. bracarensis and one was
C. norvegensis. The use
of standard mycologic phenotyping, including the assimilation
patterns, correctly identified only 4 of the 18 white colony-producing
isolates; these 4 isolates were the same 4
C. glabrata clinical
isolates whose identifications were also reconfirmed by sequencing.
Unfortunately, the assimilation patterns were not helpful for
the identification of the other isolates since
C. bracarensis and
C. nivariensis are not in the API database and since this
group of species assimilates only a few carbohydrates (0 to
2 carbohydrates, not including glucose), yielding multiple species
with the same biocode and low probabilities of correct identifications.
This low level of reactivity not only limits the discriminatory
patterns for identification but also may contribute to the lack
of color production by these species.
The 13 isolates that produced white colonies were recovered from specimens representing five anatomic sites (Table 3). Ten isolates were recovered from three nondeep sites (urine, stool, and throat) and included all three species. For seven of these isolates, a review of the patients' charts did not reveal evidence of infection; therefore, the positive cultures likely represented colonizations. For two of the C. glabrata isolates recovered from urine, there was insufficient clinical information to determine whether the positive cultures represented infection or colonization. The remaining four isolates (two C. glabrata isolates, one C. bracarensis isolate, and one C. norvegenesis isolate) were recovered from patients with clinical evidence of infections caused by these organisms. The C. bracarensis isolate was recovered operatively from an intra-abdominal abscess in an immunocompetent 67-year-old woman with a history of perforated diverticulitis (3). C. norvegenesis was recovered via straight catheterization from the urine of a 43-year-old woman with a history of end-stage renal disease and kidney transplantation who had recurrent urinary tract infections caused by a yeast. One isolate of C. glabrata was recovered in a sterile fashion from a peripancreatic fluid collection recovered from a 67-year-old man with end-stage renal disease and chronic pancreatitis with infected pseudocysts. Finally, another isolate of C. glabrata was recovered from the blood of a 49-year-old man undergoing chemotherapy for relapsed chronic myelogenous leukemia.
In conclusion, we have generated data that supported our hypothesis.
Five of seven selected species produced white colonies on CAC.
These included
C. glabrata; two other members of the
C. glabrata clade,
C. bracarensis and
C. nivariensis; and two of four of
the species with overlapping phenotypic traits,
C. norvegensis and
C. inconspicua. Four of the five species that produced white
colonies were not identifiable by the commonly used phenotypic
assays. These data may contribute to the use of chromogenic
media in the clinical mycology laboratory. Isolates with white
colonies might indicate that molecular assays might be required
for identification.

ACKNOWLEDGMENTS
We thank the staff of The Johns Hopkins Hospital Clinical Mycology
Laboratory for collecting the panel of clinical isolates used
in this study.

FOOTNOTES
* Corresponding author. Mailing address: Department of Pathology, The Johns Hopkins Medical Institutions, Meyer B1-193, 600 N. Wolfe St., Baltimore, MD 21112. Phone: (410) 955-5077. Fax: (410) 614-8087. E-mail:
wmerz{at}jhmi.edu 
Published ahead of print on 6 August 2008. 
Present address: Walter Reed Army Medical Center, 6900 Georgia Ave. NW, Washington, DC 20307. 

REFERENCES
1 - Alcoba-Florez, J., S. Mendez-Alvarez, J. Cano, J. Guarro, E. Perez-Roth, and M. del Pilar Arevalo. 2005. Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J. Clin. Microbiol. 43:4107-4111.[Abstract/Free Full Text]
2 - Baumgartner, C., A.-M. Freydiere, and Y. Gille. 1996. Direct identification and recognition of yeast species from clinical material by using Albicans ID and CHROMagar Candida plates. J. Clin. Microbiol. 34:454-456.[Abstract]
3 - Bishop, J. A., N. Chase, S. S. Magill, C. P. Kurtzman, M. J. Fiandaca, and W. G. Merz. 2008. Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection. J. Clin. Microbiol. 46:443-446.[Abstract/Free Full Text]
4 - Correia, A., P. Sampaio, S. James, and C. Pais. 2006. Candida bracarensis, sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata. Int. J. Syst. Evol. Microbiol. 56:313-317.[Abstract/Free Full Text]
5 - Jabra-Rizk, M. A., T. M. Brenner, M. Romagnoli, A. A. M. A. Baqui, W. G. Merz, W. A. Falkler, Jr., and T. F. Meiller. 2001. Evaluation of reformulated CHROMagar Candida. J. Clin. Microbiol. 39:2015-2016.[Abstract/Free Full Text]
6 - Kurtzman, C. P., and C. J. Robnett. 1998. Identification and phylogeny of ascomycetous yeasts from analysis of nuclear large subunit (26S) ribosomal DNA partial sequences. Antonie van Leeuwenhoek 73:331-371.[CrossRef][Medline]
7 - Murray, C. K., M. L. Beckius, J. A. Green, and D. R. Hospenthal. 2005. Use of chromogenic medium in the isolation of yeasts from clinical specimens. J. Med. Microbiol. 54:981-985.[Abstract/Free Full Text]
8 - Odds, F. C., and R. Bernaerts. 1994. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol. 32:1923-1929.[Abstract/Free Full Text]
9 - Odds, F. C., and A. Davidson. 2000. "Room temperature" use of CHROMagar Candida. Diagn. Microbiol. Infect. Dis. 38:147-150.[CrossRef][Medline]
10 - Reference deleted.
11 - Pfaller, M. A., A. Houston, and S. Coffman. 1996. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J. Clin. Microbiol. 34:58-61.[Abstract]
12 - Powell, H. L., C. A. Sand, and R. P. Rennie. 1998. Evaluation of CHROMagar Candida for presumptive identification of clinically important Candida species. Diagn. Microbiol. Infect. Dis. 32:201-204.[CrossRef][Medline]
Journal of Clinical Microbiology, October 2008, p. 3498-3500, Vol. 46, No. 10
0095-1137/08/$08.00+0 doi:10.1128/JCM.00982-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.